{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:06:04Z","timestamp":1791338764095,"version":"4.3.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ejmech.2015.10.044","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T01:30:27Z","timestamp":1446600627000},"page":"785-792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["A fast and specific method to screen for intracellular amyloid inhibitors using bacterial model systems"],"prefix":"10.1016","volume":"121","author":[{"given":"Susanna","family":"Navarro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5972-7448","authenticated-orcid":false,"given":"Anita","family":"Carija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Mu\u00f1oz-Torrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9652-6351","authenticated-orcid":false,"given":"Salvador","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2015.10.044_bib1","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2174\/092986708784534938","article-title":"Recent structural and computational insights into conformational diseases","volume":"15","author":"Fernandez-Busquets","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.10.044_bib2","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.biocel.2012.05.023","article-title":"Protein aggregation: mechanisms and functional consequences","volume":"44","author":"Invernizzi","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejmech.2015.10.044_bib3","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/nature02261","article-title":"Protein folding and misfolding","volume":"426","author":"Dobson","year":"2003","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ejmech.2015.10.044_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0002-9440(10)64700-1","article-title":"Intraneuronal A\u03b242 accumulation in human brain","volume":"156","author":"Gouras","year":"2000","journal-title":"Am. J. Pathology"},{"key":"10.1016\/j.ejmech.2015.10.044_bib5","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"issue":"17","key":"10.1016\/j.ejmech.2015.10.044_bib6","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/anie.200802808","article-title":"Alzheimer's disease: from pathology to therapeutic approaches","volume":"48","author":"Jakob-Roetne","year":"2009","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2015.10.044_bib7","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/cbic.200900666","article-title":"Strategies for the inhibition of protein aggregation in human diseases","volume":"11","author":"Bartolini","year":"2010","journal-title":"ChemBioChem"},{"key":"10.1016\/j.ejmech.2015.10.044_bib8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/156802607779318262","article-title":"Disrupting-amyloid aggregation for Alzheimer's disease treatment","volume":"7","author":"Estrada","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.10.044_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/ddr.20290","article-title":"Small molecule inhibitors of A aggregation and neurotoxicity","volume":"70","author":"Hawkes","year":"2009","journal-title":"Drug Dev. Res."},{"issue":"7","key":"10.1016\/j.ejmech.2015.10.044_bib10","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.bbapap.2010.04.001","article-title":"Molecular mechanism of Thioflavin-T binding to amyloid fibrils","volume":"1804","author":"Biancalana","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.ejmech.2015.10.044_bib11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jsb.2005.06.006","article-title":"Mechanism of thioflavin T binding to amyloid fibrils","volume":"151","author":"Khurana","year":"2005","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.ejmech.2015.10.044_bib12","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1002\/cbic.200700427","article-title":"Insight into the kinetic of amyloid (1-42) peptide self-aggregation: elucidation of inhibitors' mechanism of action","volume":"8","author":"Bartolini","year":"2007","journal-title":"ChemBioChem"},{"issue":"22","key":"10.1016\/j.ejmech.2015.10.044_bib13","doi-asserted-by":"crossref","first-page":"9521","DOI":"10.1021\/jm301186p","article-title":"Discovery of novel inhibitors of amyloid \u03b2-peptide 1-42 aggregation","volume":"55","author":"L\u00f3pez","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.10.044_bib14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/aps.2011.14","article-title":"Small molecule inhibitors of amyloid beta peptide aggregation as a potential therapeutic strategy for Alzheimer's disease","volume":"32","author":"Nie","year":"2011","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2015.10.044_bib15","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1242\/dmm.007963","article-title":"Development and validation of a yeast high-throughput screen for inhibitors of Abeta42 oligomerization","volume":"4","author":"Park","year":"2011","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.ejmech.2015.10.044_bib16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/biot.200500001","article-title":"Using budding yeast to screen for anti-prion drugs","volume":"1","author":"Tribouillard","year":"2006","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.ejmech.2015.10.044_bib17","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1039\/c0mb00297f","article-title":"Linking amyloid protein aggregation and yeast survival","volume":"7","author":"Morell","year":"2011","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.ejmech.2015.10.044_bib18","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1475-2859-11-166","article-title":"Modelling amyloids in bacteria","volume":"11","author":"Villar-Piqu\u00e9","year":"2012","journal-title":"Microb. Cell Fact."},{"issue":"8","key":"10.1016\/j.ejmech.2015.10.044_bib19","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.tibs.2009.03.009","article-title":"Amyloids in bacterial inclusion bodies","volume":"34","author":"de Groot","year":"2009","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejmech.2015.10.044_bib20","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nrm2993","article-title":"Cellular strategies for controlling protein aggregation","volume":"11","author":"Tyedmers","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2015.10.044_bib21","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/cbic.201000602","article-title":"Bacterial inclusion bodies of Alzheimer's disease \u03b2-amyloid peptides can be employed to study native-like aggregation intermediate states","volume":"12","author":"Dasari","year":"2011","journal-title":"ChemBioChem"},{"key":"10.1016\/j.ejmech.2015.10.044_bib22","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jmb.2005.02.030","article-title":"Amyloid-like properties of bacterial inclusion bodies","volume":"347","author":"Carrio","year":"2005","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2015.10.044_bib23","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1371\/journal.pbio.0060195","article-title":"Bacterial inclusion bodies contain amyloid-like structure","volume":"6","author":"Wang","year":"2008","journal-title":"Plos Biol."},{"issue":"11","key":"10.1016\/j.ejmech.2015.10.044_bib24","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1039\/c2mb25214g","article-title":"Thioflavin-S staining coupled to flow cytometry. A screening tool to detect in\u00a0vivo protein aggregation","volume":"8","author":"Espargaro","year":"2012","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.ejmech.2015.10.044_bib25","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.2174\/09298673113206660256","article-title":"Thioflavin-S staining of bacterial inclusion bodies for the fast, simple, and inexpensive screening of amyloid aggregation inhibitors","volume":"21","author":"Pouplana","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.10.044_bib26","first-page":"59","article-title":"An improved and cost-effective methodology for the reduction of autofluorescence in direct immunofluorescence studies on formalin-fixed paraffinembedded tissues","volume":"51","author":"Viegas","year":"2007","journal-title":"Eur. J. Histochem."},{"key":"10.1016\/j.ejmech.2015.10.044_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv338","article-title":"Thioflavin T as a fluorescence probe for monitoring RNA metabolism at molecular and cellular levels","author":"Sugimoto","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"37","key":"10.1016\/j.ejmech.2015.10.044_bib28","doi-asserted-by":"crossref","first-page":"20061","DOI":"10.1039\/C4CP02838D","article-title":"Mechanistic aspects of thioflavin-T self-aggregation and DNA binding: evidence for dimer attack on DNA grooves","volume":"16","author":"Biancardi","year":"2014","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.ejmech.2015.10.044_bib29","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1111\/j.1742-4658.2009.07307.x","article-title":"The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds","volume":"276","author":"Hudson","year":"2009","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2015.10.044_bib30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12013-010-9138-4","article-title":"Novel cell- and tissue-based assays for detecting misfolded and aggregated protein accumulation within aggresomes and inclusion bodies","volume":"60","author":"Shen","year":"2011","journal-title":"Cell Biochem. Biophys."},{"issue":"10","key":"10.1016\/j.ejmech.2015.10.044_bib31","first-page":"1259","article-title":"Fluorescent dye ProteoStat to detect and discriminate intracellular amyloid-like aggregates in Escherichia coli","volume":"9","author":"Navarro","year":"2014","journal-title":".\u00a0Biotechnol. J."},{"key":"10.1016\/j.ejmech.2015.10.044_bib32","article-title":"Resveratrol reduces amyloid-beta (Abeta)-induced paralysis through targeting proteostasis in an Alzheimer model of Caenorhabditis elegans","author":"Regitz","year":"2015","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.ejmech.2015.10.044_bib33","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1021\/jm200840c","article-title":"Huprine\u2212tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer's and prion diseases","volume":"55","author":"Galdeano","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.10.044_bib34","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1021\/jm401824w","article-title":"Synthesis and multitarget biological profiling of a novel family of rhein derivatives as disease-modifying anti-Alzheimer agents","volume":"57","author":"Viayna","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.10.044_bib35","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1021\/jm900859q","article-title":"Pyrano[3,2-c]quinoline\u22126-chlorotacrine hybrids as a novel family of acetylcholinesterase- and \u03b2-amyloid-directed anti-Alzheimer compounds","volume":"52","author":"Camps","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.10.044_bib36","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejmech.2014.07.021","article-title":"Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting \u03b2-amyloid, tau, and cholinesterase pathologies","volume":"84","author":"Di Pietro","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.10.044_bib37","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/cmdc.201000322","article-title":"Novel huprine derivatives with inhibitory activity toward \u03b2-amyloid aggregation and formation as disease-modifying anti-Alzheimer drug candidates","volume":"5","author":"Viayna","year":"2010","journal-title":"ChemMedChem."},{"issue":"5","key":"10.1016\/j.ejmech.2015.10.044_bib38","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.bbamcr.2014.01.020","article-title":"Selection against toxic aggregation-prone protein sequences in bacteria","volume":"1843","author":"Navarro","year":"2014","journal-title":"Biochimica Biophysica Acta Mol. Cell Res."},{"issue":"2\u20133","key":"10.1016\/j.ejmech.2015.10.044_bib39","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jmb.2011.12.014","article-title":"The effect of amyloidogenic peptides on bacterial aging correlates with their intrinsic aggregation propensity","volume":"421","author":"Villar-Pique","year":"2012","journal-title":"J.\u00a0Mol. Biol."},{"issue":"7","key":"10.1016\/j.ejmech.2015.10.044_bib40","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1517\/17425255.2014.915028","article-title":"Pharmacokinetic and pharmacodynamic evaluation of donepezil for the treatment of Alzheimer's disease","volume":"10","author":"Prvulovic","year":"2014","journal-title":"Expert Opin. Drug Metab. Toxicol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523415303263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523415303263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T05:33:13Z","timestamp":1556343193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523415303263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":40,"alternative-id":["S0223523415303263"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2015.10.044","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A fast and specific method to screen for intracellular amyloid inhibitors using bacterial model systems","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2015.10.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}